Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

8.06
Delayed Data
As of 4:00pm ET
 -0.65 / -7.46%
Today’s Change
5.57
Today|||52-Week Range
10.95
-25.30%
Year-to-Date
Can These Upstarts Knock Gilead Sciences Off Its Perch?
Jun 22 / MotleyFool.com - Paid Partner Content
Why Achillion Pharmaceuticals Is Down Big in 2016
Jun 20 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close8.71
Today’s open8.25
Day’s range8.04 - 8.44
Volume1,628,011
Average volume (3 months)1,518,070
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+94.29%
Earnings growth (this year)-1,517.86%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales20.49
Price/Book2.65

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...-1.07-4.07%
CXRXConcordia Healthcare...-2.64-11.00%
EBSEmergent BioSolution...-1.31-4.27%
INVAInnoviva Inc-0.90-8.02%
Data as of 4:04pm ET, 06/24/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$66.1M
Annual profit (last year)-$5.0M
Net profit margin-7.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts

Partner Offers

Search for Jobs